F-1: Rezolve AI Eyes Public Markets with Share Resale Registration
Registration Statement
Rezolve AI Limited is registering for resale up to 58,444,822 Ordinary Shares by existing selling securityholders.
Summary
- Rezolve AI Limited has filed a registration statement for the resale of up to 58,444,822 Ordinary Shares.
- The shares are being offered by selling securityholders and include shares from convertible notes, promissory notes, and a standby equity purchase agreement with YA II PN, LTD.
- Rezolve will not receive any proceeds from the sale of these shares.
- The company will bear the expenses associated with the registration, excluding underwriting discounts and commissions.
- The Ordinary Shares are traded on The Nasdaq Stock Market LLC ( Nasdaq ) under the symbols RZLV.
- On January 8, 2025, the closing price of the Ordinary Shares was $2.97 per share.
- The sale of shares by the Selling Holders, or the perception in the market that the Selling Securityholders of a large number of shares intend to sell shares, could increase the volatility of the market price of the Ordinary Shares or result in a significant decline in the public trading price of the Ordinary Shares.
Sentiment
Score: 4
Explanation: The document is primarily factual, but the presence of numerous risk factors and the potential for share price volatility temper any positive sentiment.
Negatives
- The sale of a large number of shares could increase volatility or decrease the share price.
Risks
- The trading price of Ordinary Shares could be volatile, and the value of Ordinary Shares may decline.
- There can be no assurance that the Public Warrants will ever be in the money at the time they become exercisable or otherwise, and they may expire worthless.
- A market for our securities may not develop or be sustained, which would adversely affect the liquidity and price of Ordinary Shares.
- Because Rezolve became a public reporting company by means other than a traditional underwritten initial public offering, the shareholders of Rezolve may face additional risks and uncertainties.
- If securities or industry analysts publish reports that are interpreted negatively by the investment community or publish negative research reports about our business, our share price and trading volume could decline.
- We are an emerging growth company, and our election to comply with the reduced disclosure requirements as a public company may make our Ordinary Shares less attractive to investors.
- Rezolve will be a foreign private issuer and, as a result, we will be permitted to rely on exemptions from certain stock exchange corporate governance standards applicable to U.S. issuers. This may afford less protection to holders of Ordinary Shares.
- We may lose our foreign private issuer status in the future, which could result in significant additional cost and expense.
- Our issuance of additional Ordinary Shares in connection with financings, acquisitions, investments, our stock incentive plans, or otherwise will dilute all other shareholders.
- We will incur increased costs as a result of operating as a public company, and our management will be required to devote substantial time to compliance with our public company responsibilities and corporate governance practices.
- In the event that we do not satisfy the conditions for re-registration as a public limited company by March 31, 2025 we will not be able to effect such re-registration by that date which could impact on the eligibility of our shares for DTC.
- U.S. holders that directly or indirectly own 10% or more of our equity interests may be subject to adverse U.S. federal income tax consequences under rules applicable to U.S. shareholders of controlled foreign corporations.
- Our U.S. shareholders may suffer adverse tax consequences if we are classified as a passive foreign investment company.
- The Internal Revenue Service may not agree that Rezolve should be treated as a non-U.S. corporation for U.S. federal income tax purposes.
- Section 7874 of the Code may limit the ability of Armada to use certain tax attributes following the Business Combination, increase Rezolves U.S. affiliates U.S. taxable income or have other adverse consequences to Rezolve and Rezolves shareholders.
Future Outlook
The Selling Holders may offer and sell the securities covered by this prospectus in a number of different ways and at varying prices.
Industry Context
This announcement is typical for companies that have recently completed a SPAC merger and have existing shareholders seeking liquidity.
Stakeholder Impact
- Public securityholders who purchased their Rezolve securities at higher prices than the Selling Holders may experience lower rates of return (if any) than the Selling Holders, due to differences in purchase prices and the potential trading price at which they may be able to sell.
- The sale of shares by the Selling Holders, or the perception in the market that the Selling Securityholders of a large number of shares intend to sell shares, could increase the volatility of the market price of the Ordinary Shares or result in a significant decline in the public trading price of the Ordinary Shares.
Next Steps
- The Selling Holders may offer and sell the securities covered by this prospectus in a number of different ways and at varying prices.
Key Dates
| Date | Description |
|---|---|
| 2021-12-17 | Original Business Combination Agreement date |
| 2022-11-10 | First Amendment to the Business Combination Agreement |
| 2023-06-16 | Amended and Restated Business Combination Agreement |
| 2023-08-04 | Amendment to the Business Combination Agreement |
| 2024-07-04 | Pre-Closing Demerger of Rezolve Limited |
| 2024-08-15 | Closing Date of the Business Combination |
| 2025-01-08 | Ordinary Shares closing price of $2.97 |
| 2025-01-10 | Date of the prospectus |
Keywords
Ordinary Shares, Resale, Registration Statement, Convertible Notes, Selling Holders, Rezolve AI, Warrants, Business Combination, Promissory Notes, Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.